Prudential Financial
UTMD icon

Prudential Financial’s Utah Medical Products UTMD Stock Holding History

Prudential Financial’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,350
Closed -$347K – 2505
2020
Q3 		$347K Buy
4,350
+369
+9% +$30.6K ﹤0.01% 2101
2020
Q2 		$353K Buy
+3,981
New +$357K ﹤0.01% 2055
2019
Q3 		– Sell
-5,639
Closed -$539K – 2474
2019
Q2 		$539K Sell
5,639
-1,261
-18% -$106K ﹤0.01% 2059
2019
Q1 		$609K Buy
6,900
+714
+12% +$62.8K ﹤0.01% 2037
2018
Q4 		$514K Buy
6,186
+1,410
+30% +$124K ﹤0.01% 1995
2018
Q3 		$449K Sell
4,776
-935
-16% -$89.3K ﹤0.01% 2073
2018
Q2 		$629K Buy
5,711
+1,900
+50% +$198K ﹤0.01% 2001
2018
Q1 		$377K Buy
3,811
+697
+22% +$62.2K ﹤0.01% 2085
2017
Q4 		$254K Buy
3,114
+194
+7% +$15.1K ﹤0.01% 2200
2017
Q3 		$215K Sell
2,920
-300
-9% -$21.6K ﹤0.01% 2240
2017
Q2 		$233K Buy
+3,220
New +$212K ﹤0.01% 2221

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prudential Financial's UTMD Position: Q4 2020 in Review

Prudential Financial sold out of Utah Medical Products (UTMD) in Q4 2020, closing a stake of 4,350 shares — an estimated $347K sold.

Prudential Financial first reported a position in UTMD in Q2 2017 and held it in 11 quarters. The position peaked at $629K in Q2 2018. 77 funds tracked by Wall St. Rank hold UTMD as of Q4 2020.

  • Prudential Financial reported no remaining Utah Medical Products position as of Q4 2020 after selling out during the quarter.
  • Prudential Financial sold 4,350 Utah Medical Products shares in Q4 2020, an estimated $347K.
  • Prudential Financial first reported a position in Utah Medical Products in Q2 2017 and held it in 11 quarters.
  • Prudential Financial's Utah Medical Products position peaked at $629K in Q2 2018.
  • 77 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2020.

Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.